| Drug Name: | Buspirone (36505-84-7) |
|---|---|
| PubChem ID: | 2477 |
| SMILES: | C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4 |
| InchiKey: | QWCRAEMEVRGPNT-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Anxiety Agents, Central Nervous System Agents, Central Nervous System Depressants, Neurotransmitter Agents, Psychotropic Drugs, Serotonin Agents, Serotonin Receptor Agonists, Tranquilizing Agents |
| Molecular Weight (dalton) | : | 385.512 |
| LogP | : | 2.0882 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 6 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 69.64 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|---|---|
| Grapefruit Juice | Dizziness | Grapefruit-medication interactions: forbidden fruit or avoidable consequences? |
| Grapefruit Juice | Increased Adverse Effects | Food–drug interaction: grapefruit juice augments drug bioavailabilityFmechanism, extent and relevance |
| Grapefruit Juice | Sedation | Grapefruit-medication interactions: forbidden fruit or avoidable consequences? |
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category